Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles
E. Kashiyama et al., Antitumor benzothiazoles. 8. Synthesis, metabolic formation, and biological properties of the C- and N-oxidation products of antitumor 2-(4-aminophenyl)benzothiazoles, J MED CHEM, 42(20), 1999, pp. 4172-4184
2-(4-Aminophenyl)benzothiazoles 1 and their N-acetylated forms have been co
nverted to C- and N-hydroxylated derivatives to investigate the role of met
abolic oxidation in the mode of action of this series of compounds. 2-(4-Am
ino-3-methylphenyl)benzothiazole (1a, DF 203, NSC 674495) is a novel and po
tent antitumor agent with selective growth inhibitory properties against hu
man cancer cell lines. Very low IC50 values (<0.1 mu M) were encountered in
the most sensitive breast cancer cell lines, MCF-7 and T-47D, whereas rena
l cell line TK-10 was weakly inhibited by la. Cell lines from the same tiss
ue origin, MDA-MB-435 (breast), CAKI-1 (renal), and A498 (renal), were inse
nsitive to 1a. Accumulation and metabolism of la were observed in sensitive
cell lines only, with the highest rate of metabolism occurring in the most
sensitive MCF-7 and T-47D cells. Thus, differential uptake and metabolism
of 1a by cancer cell lines may underlie its selective profile of anticancer
activity. A major metabolite in these sensitive cell lines has been identi
fied as 2-(4-amino-3-methylphenyl)-6-hydroxybenzothiazole (6c). Hydroxylati
on of 1a was not detected in the homogenate of previously untreated MCF-7,
T-47D, and TK-10 cells but was readily observed in homogenates of sensitive
cells that were pretreated with 1a. Accumulation and covalent binding of [
C-14]1a derived radioactivity was observed in the sensitive MCF-7 cell line
but not in the insensitive MDA-MB-435 cell line. The mechanism of growth i
nhibition by 1a, which is unknown, may be dependent on the differential met
abolism of the drug to an activated form by sensitive cell Lines only and i
ts covalent binding to an intracellular protein. However, the 6-hydroxy der
ivative 6c is not the 'active' metabolite since, like all other C- and N-hy
droxylated benzothiazoles examined in this study, it is devoid of antitumor
properties in vitro.